Free tool
Diagnostics stocks
We cover 1 company grouped under the Diagnostics theme. The median market value in the group is $370.48M. Across the group, the median move over the past trading day is −0.64%. Price change over the past year runs from −48.8% to −48.8% across the middle 80 percent of the group, with a median of −48.8%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
1 company of 150 matches these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 0K3W.L | Myriad Genetics, Inc. | $370.48M | Small cap | −48.77% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.